Tidal Investments LLC Has $889,000 Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Tidal Investments LLC reduced its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 11.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 99,213 shares of the pharmacy operator’s stock after selling 13,353 shares during the quarter. Tidal Investments LLC’s holdings in Walgreens Boots Alliance were worth $889,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of WBA. Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in Walgreens Boots Alliance by 1.6% during the 2nd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 65,690 shares of the pharmacy operator’s stock valued at $795,000 after purchasing an additional 1,038 shares during the period. Sequoia Financial Advisors LLC lifted its holdings in Walgreens Boots Alliance by 4.4% in the third quarter. Sequoia Financial Advisors LLC now owns 25,215 shares of the pharmacy operator’s stock valued at $226,000 after buying an additional 1,063 shares during the period. Assenagon Asset Management S.A. boosted its stake in Walgreens Boots Alliance by 4.0% in the second quarter. Assenagon Asset Management S.A. now owns 27,699 shares of the pharmacy operator’s stock valued at $335,000 after acquiring an additional 1,069 shares during the last quarter. Lincluden Management Ltd. grew its holdings in Walgreens Boots Alliance by 0.4% during the 3rd quarter. Lincluden Management Ltd. now owns 264,644 shares of the pharmacy operator’s stock worth $2,371,000 after acquiring an additional 1,074 shares during the period. Finally, Blue Trust Inc. raised its position in shares of Walgreens Boots Alliance by 87.0% during the 2nd quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after acquiring an additional 1,081 shares during the last quarter. 58.59% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Barclays upped their price target on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 16th. Bank of America lowered their target price on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research note on Wednesday, September 4th. Royal Bank of Canada reduced their price target on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating on the stock in a research report on Wednesday, December 4th. Evercore ISI upped their price objective on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a research report on Wednesday, October 16th. Finally, UBS Group lifted their target price on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a report on Thursday, October 17th. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $12.58.

Walgreens Boots Alliance Trading Up 2.1 %

Shares of NASDAQ:WBA opened at $9.55 on Friday. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $27.05. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. The company has a market capitalization of $8.26 billion, a P/E ratio of -0.95, a price-to-earnings-growth ratio of 1.36 and a beta of 0.66. The company has a 50-day simple moving average of $9.34 and a 200 day simple moving average of $10.55.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business had revenue of $37.50 billion for the quarter, compared to analysts’ expectations of $35.75 billion. During the same quarter in the prior year, the business earned $0.67 EPS. The firm’s revenue for the quarter was up 5.9% on a year-over-year basis. Sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, December 12th. Stockholders of record on Monday, November 18th were paid a dividend of $0.25 per share. The ex-dividend date was Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 10.47%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently -9.99%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.